Ab&B Bio-Tech Updates Board Composition and Committee Assignments

Bulletin Express
05/27

Ab&B Bio-Tech CO., LTD. JS announced the latest configuration of its Board of Directors and the corresponding committee assignments. The Board now comprises eight members, including three executive directors, two non-executive directors, and three independent non-executive directors.

Executive leadership is headed by Chairman Mr. An Youcai, who also chairs the Strategy Committee. The other executive directors are Ms. Li Runxiang and Mr. He Yiming.

Non-executive representation consists of Mr. Yu Jianlin and Mr. Du Mu.

Independent oversight is provided by Mr. Li Xiangming, Mr. Li Jianjun, Mr. Chen Chengbei, and Ms. Lui Mei Ka.

Committee leadership is structured as follows: • Audit Committee – chaired by Mr. Li Jianjun • Remuneration and Appraisal Committee – chaired by Mr. Chen Chengbei • Nomination Committee – chaired by Mr. Li Xiangming • Strategy Committee – chaired by Mr. An Youcai

The disclosure reiterates Ab&B Bio-Tech’s adherence to corporate governance guidelines by clearly defining responsibilities across its four key committees.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10